Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2007
12/27/2007US20070298464 Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same
12/27/2007US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
12/27/2007US20070298460 Novel receptor that causes cell death
12/27/2007US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease
12/27/2007US20070298457 Soluble endoproteases for the in vitro processing of recombinant proteins
12/27/2007US20070298455 Method For Preparing A Modified Host Cell
12/27/2007US20070298449 Utilization of Cell Forcibly Expressing Toll-Like Receptor
12/27/2007US20070298445 Cancer Therapeutic
12/27/2007US20070298443 Screening Method Using Antibody Heavy Chains
12/27/2007US20070298437 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a chloride intracellular channel 1 protein
12/27/2007US20070298434 Library of Toxin Mutants, and Methods of Using Same
12/27/2007US20070298430 Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein
12/27/2007US20070298418 Molecules Involved in Protein Folding
12/27/2007US20070298417 Constructs for gene expression analysis
12/27/2007US20070298415 Method of Amplifying Nucleic Acid
12/27/2007US20070298414 Engineering Enzymes Through Genetic Selection
12/27/2007US20070298145 Enzymes
12/27/2007US20070298118 Exosome transfer of nucleic acids to cells
12/27/2007US20070298056 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
12/27/2007US20070298054 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation
12/27/2007US20070298048 Non-viral gene delivery system
12/27/2007US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same
12/27/2007US20070298041 Ligands That Enhance Endogenous Compounds
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298037 administering antagonist to ztnfr14 comprising antibodies, antibody fragments, proteins or polypeptides, for the treatment of psoriasis, inflammatory bowel disease or multiple sclerosis in mammals
12/27/2007US20070298036 PRO71238 Polypeptides
12/27/2007US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection
12/27/2007US20070298026 Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta
12/27/2007US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury
12/27/2007US20070298014 Probiotic therapy of neonatal meningitis and method of using E. coli virulence determinants
12/27/2007US20070298006 Dendritic Polymers With Enhanced Amplification and Interior Functionality
12/27/2007US20070297984 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses
12/27/2007US20070295252 Gene regulatory element polynucleotide molecules isolated from the Zea mays genes fructose 1-6 bisphosphate aldolase (FDA), pyruvate orthophosphate dikinase (PPDK), or ribulose bisphosphate carboxylase activase (RUA)
12/27/2007DE102006029620A1 Polynucleotides useful for producing plants with increased cold and salt stress resistance are derived from the marine diatom Fragilariopsis cylindrus
12/27/2007DE102006029129A1 Pathogen induzierbarer synthetischer Promotor Pathogen inducible synthetic promoter
12/27/2007CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007CA2805052A1 Pathogen-inducible synthetic promoter
12/27/2007CA2691767A1 Dna molecules and methods
12/27/2007CA2658926A1 Cosmid vector for transforming plant and use thereof
12/27/2007CA2657998A1 Preparation of dough and baked products
12/27/2007CA2657217A1 Dna composition against tumor stromal antigen fap and methods of use thereof
12/27/2007CA2656707A1 Nucleic acid molecules encoding an enzyme that degrades long chain n-alkanes
12/27/2007CA2656259A1 Process for producing poxviruses and poxvirus compositions
12/27/2007CA2656258A1 Use of plant chromatin remodeling genes for modulating plant architecture and growth
12/27/2007CA2656022A1 Single-molecule pcr on microparticles in water-in-oil emulsions
12/27/2007CA2655957A1 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
12/27/2007CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007CA2655882A1 Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene
12/27/2007CA2655544A1 Fatty acid hydroxylases and uses thereof
12/27/2007CA2655497A1 Dpyd gene variants and use thereof
12/27/2007CA2655121A1 Dna fragmentation assay
12/27/2007CA2652461A1 Antifungal polypeptides and uses therof in inducing fungal resistance in plants
12/26/2007EP1870709A1 Probe array and process for producing the same
12/26/2007EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors
12/26/2007EP1870472A1 Model animal of Alzheimer's disease and use thereof
12/26/2007EP1870471A1 Method for generation of mutants in Plants
12/26/2007EP1870470A2 Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
12/26/2007EP1870469A1 Novel altered gene from rice anthranilic acid synthase gene oasa2 and use thereof
12/26/2007EP1870468A2 LPS with reduced toxicity from genetically modified gram negative bacteria
12/26/2007EP1870467A1 Polypeptide hormone Phosphatonin
12/26/2007EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer
12/26/2007EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies
12/26/2007EP1870464A2 Methods and compositions for inhibiting neoplastic cell growth
12/26/2007EP1870463A1 High-affinity rna aptamer molecule for glutathione s-transferase protein
12/26/2007EP1870462A1 Method for extracting nucleic acid
12/26/2007EP1870461A2 Method for identifying within a mammal a DNA encoding physiologically active polypeptide
12/26/2007EP1870460A1 Methods of producing proteins having triple-helix structure
12/26/2007EP1870459A1 Methods for producing polypeptides by regulating polypeptide association
12/26/2007EP1870458A1 sc(Fv)2 STRUCTURAL ISOMERS
12/26/2007EP1870457A1 Dipeptide crystals and process for production thereof
12/26/2007EP1870456A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
12/26/2007EP1870454A1 Method for producing dipeptide
12/26/2007EP1870453A1 Novel protease, microorganism producing the same, and application thereof
12/26/2007EP1870422A1 Means for the treatment of diseases characterized by an excessive immune reaction
12/26/2007EP1870421A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
12/26/2007EP1870417A2 Peptide acceptor ligation methods
12/26/2007EP1869961A2 Automated seed sampler and methods of sampling, testing and bulking seeds
12/26/2007EP1869464A2 Rage/diaphanous interaction and related compositions and methods
12/26/2007EP1869210A2 Peptide stabilizer compounds and screening method
12/26/2007EP1869193A1 Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
12/26/2007EP1869192A2 Framework-shuffling of antibodies
12/26/2007EP1869191A1 Novel neural cell specific promoter and baculovirus and method for gene delivery
12/26/2007EP1869190A1 Gene delivery system containing decorin gene and pharmaceutical composition for treating cancer containing the system
12/26/2007EP1869189A2 Alteration of plant embryo/endosperm size during seed development
12/26/2007EP1869188A1 Cis-acting regulatory elements from tripsacum dactyloides
12/26/2007EP1869187A2 Elite event a2704-12 and methods and kits for identifying such event in biological samples
12/26/2007EP1869186A2 Methods and means for removal of a selected dna sequence
12/26/2007EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer
12/26/2007EP1869184A1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87
12/26/2007EP1869183A2 Theileria parva dna vaccines
12/26/2007EP1869182A1 Method for isolation of soluble polypeptides
12/26/2007EP1869181A2 Influenza therapeutic
12/26/2007EP1869179A2 Method for treating a sample that contains biomolecules
12/26/2007EP1869178A1 Promoter for the expression of foreign genes in neuronal cells
12/26/2007EP1869177A2 A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure
12/26/2007EP1869176A1 Apparatus for recovering specific substance and nucleic acid extracting apparatus using the same
12/26/2007EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength
12/26/2007EP1869160A2 Gene inactivated mutants with altered protein production
12/26/2007EP1869089A1 Phosphorylated waxy potato starch
12/26/2007EP1869085A2 Novel anti-plgf antibody